EUVIMEDEUVIMED entdecken
Crossref

Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population

Karla Beatriz Cardias Cereja-Pantoja, Tereza Cristina de Brito Azevedo, Lui Wallacy Morikawa Souza Vinagre, Francisco Cezar Aquino de Moraes iD, Giovanna Gilioli da Costa Nunes, Natasha Monte, Angélica Leite de Alcântara, Amanda Cohen-Paes, Marianne Rodrigues Fernandes, Sidney Emanuel Batista Dos Santos, Paulo Pimentel de Assumpção, Ândrea Kely Ribeiro Dos Santos und 4 weitere

Cancer Chemotherapy and Pharmacology · 2024

DOI: 10.1007/s00280-024-04689-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von Karla Beatriz Cardias Cereja-Pantoja und 15 weiteren Autor:innen. Beteiligte Einrichtung: Núcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, 66073-005, Brazil. Hauptthemen laut MEDLINE: Imatinib Mesylate, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Drug Resistance, Neoplasm, Protein Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Pró-Reitoria de Pesquisa e Pós-Graduação, Universidade Federal do Pará.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Imatinib MesylateLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDrug Resistance, NeoplasmProtein Kinase InhibitorsAntineoplastic AgentsPolymorphism, Single NucleotideHumansMaleFemaleMiddle AgedAdultAgedPharmacogeneticsGenotypeYoung Adult

Stichwörter der Autor:innen

Chronic myeloid leukemiaImatinibTherapyVariants

Substanzen

Imatinib MesylateProtein Kinase InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Núcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, 66073-005, Brazil.
  • Ophir Loyola Hospital, Belém, PA, 66063-240, Brazil.
  • Núcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, 66073-005, Brazil. francisco.cezar2205@gmail.com.
  • Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas - CiMUS, Universidad de Santiago de Compostela, Santiago de Compostela, 15782, Spain.

ORCID-Profile: Francisco Cezar Aquino de Moraes

Förderung

  • Pró-Reitoria de Pesquisa e Pós-Graduação, Universidade Federal do Pará

Zitieren

APA

Cereja-Pantoja, K. B. C., de Brito Azevedo, T. C., Vinagre, L. W. M. S., de Moraes, F. C. A., da Costa Nunes, G. G., Monte, N., de Alcântara, A. L., Cohen-Paes, A., Fernandes, M. R., Batista Dos Santos, S. E., de Assumpção, P. P., Ribeiro Dos Santos, Â. K., Burbano, R. M. R., Guerrero, R. C., Carracedo, Á., & Carneiro Dos Santos, N. P. (2024). Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04689-x

Vancouver

Cereja-Pantoja KBC, de Brito Azevedo TC, Vinagre LWMS, de Moraes FCA, da Costa Nunes GG, Monte N, et al. Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04689-x

BibTeX
@article{CerejaPantoja2024,
  author = {Cereja-Pantoja, Karla Beatriz Cardias and de Brito Azevedo, Tereza Cristina and Vinagre, Lui Wallacy Morikawa Souza and de Moraes, Francisco Cezar Aquino and da Costa Nunes, Giovanna Gilioli and Monte, Natasha and de Alcântara, Angélica Leite and Cohen-Paes, Amanda and Fernandes, Marianne Rodrigues and Batista Dos Santos, Sidney Emanuel and de Assumpção, Paulo Pimentel and Ribeiro Dos Santos, Ândrea Kely and Burbano, Rommel Mario Rodríguez and Guerrero, Raquel Cruz and Carracedo, Ángel and Carneiro Dos Santos, Ney Pereira},
  title = {Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2024},
  doi = {10.1007/s00280-024-04689-x}
}
Kostenlos starten →